Published in
Oxford University Press, Clinical Infectious Diseases, 11(70), p. 2435-2438, 2019
DOI: 10.1093/cid/ciz762
Links
Tools
Recurrence and Occurrence of Kaposi’s Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia
Journal article published in 2020 by
Romain Palich,
Marianne Veyri,
Marc-Antoine Valantin,
Anne-Geneviève Marcelin,
Amélie Guihot,
Valérie Pourcher,
Aude Jary 
,
Caroline Solas,
Alain Makinson,
Isabelle Poizot-Martin,
Dominique Costagliola ,
Jean-Philippe Spano,
Christine Katlama,
,
for the CancerVIH Study Group
and other authors.
,
Caroline Solas,
Alain Makinson,
Isabelle Poizot-Martin,
Dominique Costagliola ,
Jean-Philippe Spano,
Christine Katlama,
,
for the CancerVIH Study Group
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Abstract In 21 cutaneous and/or visceral Kaposi’s sarcoma cases, occurring in patients living with human immunodeficiency virus (HIV) who were on antiretroviral therapy with suppressed HIV viremia and high CD4 T cell counts, the efficacy of conventional chemotherapies was limited due to cumulative toxicities, comedications, and a lack of immune improvement.